This study is testing a drug called **vudalimab (XmAb20717)** in people with certain advanced cancers, specifically in the **gynecologic** (female reproductive system) and **genitourinary** (urinary system and male reproductive organs) areas. The study has two stages: In **Stage 1**, different groups of 10 people each with specific cancer types will try the drug to see if it helps. If at least 2 people in a group show improvement, more people will join in **Stage 2** to see if the drug continues to work well.
Participants must be adults (18+), have tried standard treatments that didn’t work, and meet specific cancer criteria. Women must use effective birth control, and men shouldn’t donate sperm during the study. You can’t join if you’re on other cancer treatments or have certain health issues.
- Study Length: The study may have multiple visits over time.
- Risks: Possible side effects from the drug, not specified in detail.
- Compensation: Not mentioned, check with the study team for details.